bioRxiv Science⌕ Search

bioRxiv · 10.64898/2025.12.19.695347

Abnormal bioelectricity during unperturbed cancer growth. Part-I: electrical biopotentials, surface charge density, volumetric charge density, phase-field and Turing approach.

Abstract

Understanding the abnormal cancer bioelectricity and its close relationship to growth is a challenge for researchers and oncologists. The objective of this study is to simulate the mechanical-electrical coevolution of solid cancer using an energetic approach, which involves the local and global changes of bioelectricity in the entire unperturbed tumor, aspects that may be correlated spatially and electrically with the growth, progression, nucleation, angiogenesis and metastasis of a unperturbed solid malignant tumor. For this, spherical harmonics, phase-field, and the Turing approach were taken into account in the model. The results showed that electrical bioptentials and volumentric charge density throughout the interior of the unperturbed tumor, as well as surface charge density at tumor-surrounding healthy tissue boundary during its growth depended on mass aggregation, time and type of spherical harmonics. Regions with both positive and negative charge densities throughout the interior of the unperturbed tumor volume were observed. We concluded that positive and negative values may be responsible for maintaining the electronegativity of the entire tumor, primarily within it, during its growth over time. It is concluded that the anomalous bioelectricity and biomechanics in unperturbed cancer are due to intratumoral electrical heterogeneity and anisotropy according to {Phi}1(r,{theta} , {varphi}),{rho} v(t),{sigma} 12 and Turing spatiotemporal patterns, depending on the degree of Ynm asymmetry, {micro}T value [Formula] and t. Anomalous bioelectricity and biomechanics are closely related and both should be considered as another hallmark of cancer because these are essentially involved in self-regulation of symmetry, global electronegativity, intratumoral biological heterogeneity and anisotropy, growth, metastasis (by electrostatic and/or electromagnetic repulsion), abnormal metabolism of unperturbed cancer, as well as its protection from attack by cellular elements of the immune system and anticancer therapies (by formation of a heterogeneous electric shield), and in the appropriate and individualized selection of anticancer therapy, either alone or in combination. Author summaryUnperturbed cancer and its growth kinetics are not fully understood, an aspect that may partially explain why its complete cure has not yet been achieved by any existing anticancer therapies. This may be because the close electrical-mechanical-chemical-biological-kinetics-hallmarks connection in unperturbed cancer is not well understood. Therefore, this study proposes a theoretical approach that reveals the explicit connection between anomalous bioelectricity (electrical properties of cancer and surrounding healthy tissue, electrical biopotentials, surface charge density and volumetric charge density) with mechanical (phase-field, cancer asymmetry degree and diffusive interface), chemical-biological (Turing approach) and kinetic (size, geometry and introduction of mass) parameters in unperturbed cancer. Simulations reveal: 1) this electrical-mechanical-chemical-biological-kinetics-hallmarks connection may be essentially governed by both electronegative and electropositive intratumoral regions, which are closely interconnected and dependent on spherical harmonic asymmetry degree and introduction of mass (less than its threshold value) during unperturbed cancer growth. 2) Greater spherical harmonic asymmetry and amount of mass introduced result in a greater degree of heterogeneity and faster growth of it. 3) Electronegative and electropositive intratumoral regions may be responsible for the self-preservation and self-regulation overtime of symmetry of electric potential and volumetric charge density spatial patterns, both global electronegativity and survival of unperturbed cancer.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Romero-Arias, R., Bergues-Cabrales, L. E., Heredia-Kindelan, J. A., Romero Rosales, D., Barrio, R. A., Bory Reyes, J., Montijano, J. I.. 2025-12-22. Abnormal bioelectricity during unperturbed cancer growth. Part-I: electrical biopotentials, surface charge density, volumetric charge density, phase-field and Turing approach.. https://doi.org/10.64898/2025.12.19.695347

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

m6A-Driven Intratumoral Cholesterol Biosynthesis Fuels Castration-Resistant Prostate Cancer Progression

Both nuclear pore complexes (NPCs) and RNA N6-methyladenosine (m6A) machinery are indispensable for proper cellular function. Although their collaborative roles in the nuclear export of messenger RNAs (mRNAs) have been reported, it remains ambiguous whether and how this collaboration may contribute to cancer progression. Here we identify a functional cooperation between NPCs and m6A signaling that promotes the development of castration-resistant prostate cancer (CRPC). We showed that nuclear export of m6A-modified mRNAs, mediated by the interaction between RNA methyltransferase METTL3 and the nucleoporin NUP93, is functionally coupled to cholesterol biosynthesis. Given that cholesterol-fueled intratumoral androgen production is one of the mechanisms driving CRPC, we demonstrated that overexpression of the wild-type METTL3 or NUP93, but neither the enzymatically dead METTL3 nor the mutant NUP93 that loses METTL3-interacting capability, elevates intracellular levels of androgens, activates AR signaling under castrate condition, and promotes androgen-independent growth of prostate cancer cells both in vitro and in vivo. Importantly, pharmacological inhibition of METTL3 or targeted demethylation on mRNAs encoding key cholesterol biosynthesis enzymes effectively suppressed CRPC malignancy. Together, these findings uncover a therapeutically targetable m6A-METTL3-NUP93 axis that links nuclear mRNA export and metabolic reprogramming to fuel CRPC progression, providing a conceptually new strategy for the treatment of this lethal disease.

cancer biology↗

ST6Gal2 promotes α2,6-sialylation and aggressive phenotypes in neuroblastoma cells

Neuroblastoma is the most common extracranial solid tumor of childhood. Its clinical behavior ranges from spontaneous regression to lethal, treatment-refractory disease. Aberrant 2,6-sialylation contributes to aggressive phenotypes in many cancers, but the role of ST6Gal2, a neural-enriched 2,6-sialyltransferase, in neuroblastoma is largely unexplored. Here, we examine the clinical and functional significance of ST6Gal2 in neuroblastoma. In two independent public cohorts (SEQC, n=498; Kocak, n=649), high ST6GAL2 expression was associated with significantly worse overall and event-free survival. In the SEQC cohort, ST6GAL2 expression was higher in high-risk and MYCN-amplified tumors, varied across International Neuroblastoma Staging System stages, and correlated positively with a mesenchymal transcriptional signature (Spearman {rho}=0.181). The mesenchymal correlation was reproduced in the Kocak cohort ({rho}=0.204). Stable shRNA-mediated knockdown of ST6GAL2 in SK-N-AS and SK-N-BE(2) cells reduced proliferation and viability, impaired wound closure, and decreased migration and invasion. In preliminary experiments in SK-N-AS cells, ST6GAL2 knockdown reduced binding of Sambucus nigra agglutinin, consistent with a role for ST6Gal2 in 2,6-sialylation. Together, these findings link ST6Gal2 expression to aggressive clinical and transcriptional features and pro-tumorigenic phenotypes in neuroblastoma and nominate ST6Gal2-mediated sialylation as a candidate pathway for mechanistic study.

cancer biology↗

Unsupervised transcriptomic analysis of paired pre- and post-treatment specimens reveals divergent chemoimmunomodulatory induction trajectories in breast cancer

The immunomodulatory effects of chemotherapy (chemoimmunomodulation; CIM) are clinically consequential and heterogeneous, yet no systematic framework exists for classifying the immunomodulatory trajectory a tumor follows in response to treatment (CIM trajectory). Here, we present the CIM Induction Classifier (CIMIC), an unsupervised clustering pipeline leveraging delta gene expression across 3,189 CIM-related genes to classify specimens chemoimmunomodulatory trajectory. Applied to two pre- and post-chemotherapy breast cancer (BC) datasets (NKI/SMC, N = 36; NEO, N = 19) and nine epirubicin-perturbed triple-negative BC (TNBC) cell lines, CIMIC identified two divergent CIM trajectories: a functional CIM (Fun-CIM) trajectory, broadly conserved across tumors and cell lines and characterized by induction of inflammatory cell death, antigen presentation, viral mimicry, and adaptive immune activation programs, and a dysfunctional CIM (Dys-CIM) trajectory, characterized by induction of proteostatic and metabolic stress-adaptation programs, reduced immune cell abundances and cytotoxic activity, and enrichment of aggressive BC subtypes. Using survival and longitudinal transcriptomic data in NKI/SMC (N = 20), treatment-induced increases in Fun-CIM-associated genes and ssGSEA scores were associated with reduced recurrence, whereas Dys-CIM-associated genes and scores were associated with increased recurrence. In multivariable analyses within independent chemotherapy-treated BC cohorts (METABRIC, N = 412; SCAN-B, N = 2,462), higher baseline Fun-CIM ssGSEA scores were associated with better outcomes, whereas higher baseline Dys-CIM ssGSEA scores were associated with worse outcomes. These findings establish CIM as a dynamic, trajectory-level process and position CIMIC as a framework for defining CIM trajectories and supporting future efforts to identify predictors, mechanisms, and therapeutic strategies that maximize beneficial CIM.

cancer biology↗